Cargando…
SARS-CoV-2 Vaccines in Kidney Transplant Recipients: Will They Be Safe and Effective and How Will We Know?
Autores principales: | Heldman, Madeleine R., Limaye, Ajit P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Nephrology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259673/ https://www.ncbi.nlm.nih.gov/pubmed/33762353 http://dx.doi.org/10.1681/ASN.2021010023 |
Ejemplares similares
-
1091. Incidence of Post-Transplant Lymphoproliferative Disorders among Epstein-Barr Virus Donor Positive, Recipient Negative Adult Solid Organ Transplant Recipients
por: Limaye, Abhijit P, et al.
Publicado: (2020) -
Predictive analytics in health care: how can we know it works?
por: Van Calster, Ben, et al.
Publicado: (2019) -
SARS-CoV-2 vaccination in cardiothoracic organ transplant recipients: effective strategies wanted
por: Ewen, Sebastian, et al.
Publicado: (2021) -
We know what we want, it’s just not there
por: Freundlich, Robert E., et al.
Publicado: (2021) -
COVID-19 in Solid Organ Transplant Recipients: a Review of the Current Literature
por: Heldman, Madeleine R., et al.
Publicado: (2021)